Considering the definition of synthetic lethality and the results presented here, we propose that KDM5C and YY1 form a synthetically lethal gene pair, providing a rationale for the clinical treatment of patients with KDM5C-deficient cancer by targeting YY1. This evidence concerns the gene YY1 and cancer.